Alnylam Pharmaceuticals
ALNY
#618
Rank
A$50.88 B
Marketcap
$393.19
Share price
3.69%
Change (1 day)
77.76%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$9.85 M-77.19%
2024A$43.18 M-16.96%
2023A$51.99 M-66.55%
2022A$0.15 B200.46%
2021A$51.74 M-9.83%
2020A$57.38 M52.34%
2019A$37.66 M46.52%
2018A$25.7 M-70.97%
2017A$88.54 M191.96%
2016A$30.32 M-14.94%
2015A$35.65 M68.07%
2014A$21.21 M152.1%
2013A$8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$3.01 MA$8.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.26 MA$51.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.8 MA$36.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.41 MA$29.64 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.09 MA$5.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.97 MA$0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$6.82 MA$53.35 M๐Ÿ‡ซ๐Ÿ‡ท France
A$12.18 MA$42.24 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel